We are live on ! Find out more
NAMSW icon

NewAmsterdam Pharma Warrant
NAMSW

18 hedge funds and large institutions have $5M invested in NewAmsterdam Pharma Warrant in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $4.53M → $5M (+$471K)

14% less funds holding

Funds holding: 21 → 18 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
18
Holders Change
-3
Holders Change %
-14.29%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
4
Closed
5
Calls
$138K
Puts
–
Net Calls
+$138K
Net Calls Change
+$73K

Top Buyers

Rank Fund Capital Flow
1
AAA
Affinity Asset Advisors
New York
+$58.7K
2
CS
Clear Street
New York
+$28K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.89M
2
ETH
Exos TFP Holdings
New York
-$68.8K
3
CCA
Castle Creek Arbitrage
Colorado
-$43K
4
PI
PEAK6 Investments
Illinois
-$36.5K
5
DCM
Dupont Capital Management
Delaware
-$6.67K
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highbridge Capital Management
New York
$1.36M – – –
FLSM
2
Frazier Life Sciences Management
California
$921K – – –
EC
3
EcoR1 Capital
California
$884K – – –
RCM
4
RA Capital Management
Massachusetts
$613K – – –
Ensign Peak Advisors
5
Ensign Peak Advisors
Utah
$278K – – –
BCLSI
6
Bain Capital Life Sciences Investors
Massachusetts
$184K – – –
ETH
7
Exos TFP Holdings
New York
$173K -$68.8K -43,385 -32%
DM
8
Deerfield Management
New York
$171K – – –
AAA
9
Affinity Asset Advisors
New York
$68.5K +$58.7K +37,000 New
WCMNY
10
Westchester Capital Management (New York)
New York
$57.7K – – –
HF
11
HRT Financial
New York
$56K – – –
Walleye Capital
12
Walleye Capital
New York
$47.8K -$3.81K -2,402 -8%
CC
13
Caxton Corporation
New Jersey
$40.5K – – –
CS
14
Clear Street
New York
$32.4K +$28K +17,619 New
PI
15
PEAK6 Investments
Illinois
$31.3K -$36.5K -23,033 -58%
LCM
16
Laurion Capital Management
New York
$30.7K – – –
Walleye Trading
17
Walleye Trading
New York
$27.5K -$2.22K -1,400 -9%
VI
18
Vestcor Inc
New Brunswick, Canada
$18K – – –
MTCM
19
Mint Tower Capital Management
Netherlands
$12K – – –
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
– -$1.89M -285,105 Closed
CCA
21
Castle Creek Arbitrage
Colorado
– -$43K -51,520 Closed
DCM
22
Dupont Capital Management
Delaware
– -$6.67K -8,333 Closed
WAM
23
Wolverine Asset Management
Illinois
– -$1.27K -1,462 Closed
UBS Group
24
UBS Group
Switzerland
– -$936 -1,076 Closed

NAMSW Hedge Fund Activity: Q1 2023 in Review

18 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in NewAmsterdam Pharma Warrant (NAMSW) for Q1 2023, worth a combined $5M — up 10% from $4.53M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of NAMSW and 2 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 0 added.

The largest buyer was Affinity Asset Advisors, opening a new position worth an estimated $58.7K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $1.89M sold.

  • 18 institutional investors held NewAmsterdam Pharma Warrant (NAMSW) as of Q1 2023, down from 21 in Q4 2022.
  • Funds reported $5M of NewAmsterdam Pharma Warrant stock for Q1 2023, up 10% quarter-over-quarter.
  • 2 funds opened new NewAmsterdam Pharma Warrant positions in Q1 2023 and 5 closed out, a net change of -3 holders.
  • The largest NewAmsterdam Pharma Warrant buyer in Q1 2023 was Affinity Asset Advisors, an estimated $58.7K added.
  • The largest NewAmsterdam Pharma Warrant seller in Q1 2023 was Alyeska Investment Group, an estimated $1.89M sold.

Based on aggregated 13F filings for Q1 2023.